Products

  „By skipping the guesswork associated with end-point assays and eliminating the time- and labor-intensive steps of traditional cell-based assays, real-time cell analysis with the xCELLigence RTCA DP vastly improves efficiency and overall productivity. By eliminating the need for labels/dyes, the physiological relevance of acquired data is maximized.“

Dr. Veréb Zoltán

Faculty of Medicine, University of Szeged, Hungary

“I used the xCELLigence DP system to study the effectiveness of CAR-T against target cancer cells. I was able to observe the effectiveness of cell therapy during the entire experiment with great accuracy. Both devices and software are easy and pleasant to use”

Dr Anna Bujak, Principal Research Scientist

Helix Immuno-Oncology, Warsaw, Poland

„Our researches are mostly focused in the context of type II Diabetes, Obesity and a broad range of applications in cell biolabeling, cancer treatment, metastasis and therapeutic drug monitoring. Compared to traditonal end-point method, xCelligence system revolutionized our workflow adding real-time monitoring of cells inside incubator as an fundamental factor to assess long term effect of different compounds of interest."

Dr Marta Kepinska

Wroclaw Medical University, Poland

The xCELLigence RTCA DP system is an easy to use platform with intuitive software and a variety of online tutorials for beginners and experience users. It is great tool for our cell therapies development, our laboratory obtained exciting results for cytotoxicity assays using adherent and suspension cells.

 

Dr Mirabela Cristea

Center for gene and cellular therapies in the treatment of cancer (OncoGen), Timisoara, Romania 

"We were delighted to use xCelligence DP in the research on the proliferation of bacterial strains in relation to antibiotic resistance and pathogenicity. The number of data collected during experiments extended these obtained by any other technique used in analysis ow grow curve. We also appreciate the fact that software provides an accessibly and convenient format of data to the statistical analysis. The result of the study will be presented at the conference: 5th International Caparica Conference in Antibiotic Resistance 2022, Portugal. We hope that xCelligence DP will permanently contribute our study soon."

Dr Tomasz Jarzembowski

Medical University of Gdańsk, Poland

xCELLigence SP - Agilent technologies

Basic tool with a huge impact for any cell based assay

The RTCA SP Station is located inside a tissue culture incubator and is capable of switching any one of the wells on the E-Plate 96 to the RTCA Analyzer for impedance measurement. Under the software of the RTCA Control Unit, the RTCA SP Analyzer can automatically select wells for measurement and continuously transfer measured impedance data to the computer. Cell Index values, derived from the measured impedances, are continuously displayed on the Software user interface.

The RTCA SP Instrument is composed of four main components:

  • RTCA Analyzer
  • RTCA SP Station
  • RTCA Control Unit
  • E-Plate 96

RTCA SP Instrument Highlights:

  • Rapid measurement time - less than 10 or 60 seconds for 96 wells
  • Compact design of the RTCA SP Station that fits conveniently in tissue culture incubators
  • High-performance electronic components and enhanced instrument reliability
  • Easy setup and customization of assay protocols
  • Integrated, on-line data analysis capability

Show more

https://www.aceabio.com/products/rtca-sp/

Discover more

Cancer Immunotherapy Applications of xCELLigence Real-Time Cell Analysis (RTCA) Systems xCELLigence cancer immunotherapy: NK cell-mediated cytolysis Real-time chemotaxis of macrophages Quantifying virus-mediated cytopathic effect with xCELLigence platform Introducing the xCELLigence Immunotherapy kit – B Cell killing assay Real-time monitoring of Human Skin-Derived Precursor (SKPs) cell differentiation Assessment of CAR T Cell killing capacity against solid tumors-Thursday, October 20, 2016, 5 pm CEST Cancer immunotherapy: Macrophage-mediated phagocytosis Monitoring in real time the formation and removal of biofilms from clinical related pathogens xCELLigence in personalized cancer medicine Investigating the hallmarks of cancer using xCELLigence system Monitoring the formation and removal of biofilms from clinically relevant pathogens in real-time Real-time determination of virus titers using cell electric impedance technology Label-free monitoring of T cell activation by the impedance-based system A novel high throughput assay for diagnosis by real-time monitoring of parasite motility Optimization of (CAR) T cell design guided by sensitive sssessment of B cell killing Cellular impedance measurement- novel method for in-vitro investigation of drug efficacy Cellular impedance measurement- response of OVCAR-3 cells to Cisplatin and hyperthermia ACEA webinar series: Using xCELLigence RTCA to study biofilms formation Protectome analysis: A new selective tool for bacterial vaccine discovery Kinase study of cytotoxicity voted paper of the year. ACEA Biosciences launch xCELLigence RTCA software Pro for immunotherapy applications New technique for dynamic monitoring of liquid tumor Cytotoxicity xCELLigence system: rapid and sensitive, ideal for infectious viral assays.
Riccardo Pasculli

Head of application support

Riccardo

Pasculli

+420 731 127 717

Send Message

Setup a demonstration
with our specialist

Request a demo

Related products

Located inside a tissue culture incubator, the RTCA DP Analyzer has three integrated stations for E-Plates 16 or CIM-Plates 16

show detail

Located inside a tissue culture incubator, it is capable of switching any one of the wells on any of six E-Plates to the RTCA Analyzer for impedance measurement

show detail

The eSight system combines the label-free xCELLigence RTCA technology with live cell imaging in 3 colors (red, green, and blue), all inside your incubator

show detail

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey